Alvotech Future Growth
Future criteria checks 5/6
Alvotech is forecast to grow earnings and revenue by 99% and 34.6% per annum respectively while EPS is expected to grow by 99.4% per annum.
Key information
99.0%
Earnings growth rate
99.4%
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | 34.6% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Alvotech's Position In The Coming Biosimilar Gold Rush
Nov 21Alvotech: Steady Progress Offers A Good Chance Of Upside
Aug 26Bullish: Analysts Just Made A Huge Upgrade To Their Alvotech (NASDAQ:ALVO) Forecasts
May 28
Alvotech: Consider Buying As Positive Q1 Earnings Release Likely
Apr 25Alvotech (NASDAQ:ALVO) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Apr 03Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 24Analysts Just Shaved Their Alvotech (NASDAQ:ALVO) Forecasts Dramatically
Sep 03Positive Sentiment Still Eludes Alvotech (NASDAQ:ALVO) Following 27% Share Price Slump
May 05Shareholders Shouldn’t Be Too Comfortable With Alvotech's (NASDAQ:ALVO) Strong Earnings
Nov 23Fuji Pharma files for approval of biosimilar candidate in Japan
Oct 17Alvotech and STADA launch Humira biosimilar in Switzerland
Sep 22Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 949 | 192 | 368 | 368 | 2 |
| 12/31/2025 | 645 | 46 | 202 | 202 | 4 |
| 12/31/2024 | 454 | -124 | 115 | 115 | 3 |
| 9/30/2024 | 394 | -441 | -301 | -265 | N/A |
| 6/30/2024 | 309 | -618 | -343 | -310 | N/A |
| 3/31/2024 | 114 | -494 | -339 | -301 | N/A |
| 12/31/2023 | 93 | -552 | -359 | -312 | N/A |
| 9/30/2023 | 64 | -596 | -356 | -309 | N/A |
| 6/30/2023 | 65 | -416 | -347 | -299 | N/A |
| 3/31/2023 | 100 | -713 | -411 | -361 | N/A |
| 12/31/2022 | 85 | -514 | -361 | -312 | N/A |
| 9/30/2022 | 96 | 61 | -388 | -319 | N/A |
| 6/30/2022 | 78 | -12 | -345 | -285 | N/A |
| 3/31/2022 | 39 | -42 | -274 | -223 | N/A |
| 12/31/2021 | 40 | -102 | -269 | -228 | N/A |
| 12/31/2020 | 69 | -170 | -86 | -74 | N/A |
| 12/31/2019 | 83 | -210 | -97 | -89 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALVO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: ALVO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALVO is expected to become profitable in the next 3 years.
Revenue vs Market: ALVO's revenue (34.6% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: ALVO's revenue (34.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALVO's Return on Equity is forecast to be high in 3 years time